Tenaya Therapeutics doses first patient with TN-401 gene therapy | Markets Insider

Retrieved on: 2024-11-25 19:40:10

Tags for this article:

Click the tags to see associated articles and topics

Tenaya Therapeutics doses first patient with TN-401 gene therapy | Markets Insider. View article details on hiswai:

Excerpt

Tenaya Therapeutics (TNYA) announced that the first patient has been dosed with TN-401 gene therapy in the RIDGE-1 Phase 1b clinical trial at th.

Article found on: markets.businessinsider.com